Company & Sponsor Intelligence

Medical College of Wisconsin

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →

Indexed trials6

Recruiting1

Completed4

Countries1

Therapeutic footprint

alzheimersautismbipolar_disorderepilepsyother_neurologyother_psychiatry

Indexed studies

NCT00199966Safety And Efficacy Study Of Depakote ER To Treat Pediatric Bipolar Disorder
bipolar_disorder · United StatesPHASE4

NCT07650188Stimulating the Aging Brain Using Brain and Sensory Stimulation
other_psychiatry · United StatesNA

NCT03513757Dexmedetomidine and Propofol for Pediatric MRI Sedation
epilepsy · United StatesPHASE4

NCT03461861Network-Level Mechanisms for Preclinical Alzheimer's Disease Development
alzheimers · United StatesPHASE2

NCT01655485Effect of a Social Script iPAD Application for Children With Autism Spectrum Disorder
autism · United StatesNA

NCT05343988Percutaneous Neurostimulation to Treat Paroxysmal Sympathetic Hyperactivity in Children
other_neurology · United StatesNA

Intelligence layer updated: 2026-10-29 06:17:44.639239+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →